February 2019 - Volume 41 - Issue 1 : Therapeutic Drug Monitoring

Previous Issue | Next Issue

February 2019 - Volume 41 - Issue 1

pp: 1-106

Table of Contents Outline

Contributor Index

Review Article

New Mass Spectrometric Approaches for the Quantitative Evaluation of Anticancer Drug Levels in Treated Patients

D'Aronco, Sara; D'Angelo, Edoardo; Crotti, Sara; More

Therapeutic Drug Monitoring. 41(1):1-10, February 2019.

Original Article

A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients

Klaasen, Rolf Anton; Egeland, Erlend Johannessen; Chan, Joe; More

Therapeutic Drug Monitoring. 41(1):11-18, February 2019.

A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry

Vethe, Nils Tore; Munkhaugen, John; Andersen, Anders M.; More

Therapeutic Drug Monitoring. 41(1):19-28, February 2019.

Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients

Neugebauer, Sophie; Wichmann, Christina; Bremer-Streck, Sibylle; More

Therapeutic Drug Monitoring. 41(1):29-37, February 2019.

Open
SDC

Low Serum Trough Concentrations and High Vancomycin Minimum Inhibitory Concentration in Methicillin-Sensitive Staphylococcus aureus From Hemodialysis Patients in Brazil

Vitória, Michel Penedo da; Alvarenga, Cristiane Gomes de Sousa; Vasconcellos Filho, Lauro Monteiro; More

Therapeutic Drug Monitoring. 41(1):38-43, February 2019.

Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children

Liu, Xiaoxi; Smits, Anne; Wang, Yuhuan; More

Therapeutic Drug Monitoring. 41(1):44-52, February 2019.

Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus–Positive Kidney Transplant Recipients

Schrezenmeier, Eva; Hoffmann, Friederike; Jaeger, Carsten; More

Therapeutic Drug Monitoring. 41(1):53-58, February 2019.

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

Daskapan, Alper; Tran, Quynh T.D.; Cattaneo, Dario; More

Therapeutic Drug Monitoring. 41(1):59-65, February 2019.

Open
SDC

Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring

Moeung, Sotheara; Chevreau, Christine; Poinsignon, Vianney; More

Therapeutic Drug Monitoring. 41(1):66-74, February 2019.

Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia

Moon, Soo Young; Lim, Ji-Hyun; Kim, Eun-Hee; More

Therapeutic Drug Monitoring. 41(1):75-85, February 2019.

Open

Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy

Suzuki, Takeshi; Mihara, Kazuo; Nagai, Goyo; More

Therapeutic Drug Monitoring. 41(1):86-90, February 2019.

Catalase C-262T Polymorphism Is a Risk Factor for Valproic Acid–Induced Abnormal Liver Function in Chinese Patients With Epilepsy

Ma, Linfeng; Pan, Yue; Sun, Ming; More

Therapeutic Drug Monitoring. 41(1):91-96, February 2019.

Short Communication

Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping

Wang, Xuebin; Yang, Yunyun; Liu, Zhengyue; More

Therapeutic Drug Monitoring. 41(1):97-101, February 2019.

Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

Kim, Eun Jung; Oh, Jaeseong; Lee, Kyounghoon; More

Therapeutic Drug Monitoring. 41(1):102-106, February 2019.

Secondary Logo

Journal Logo